CC
CATX icon

Commodore Capital’s Perspective Therapeutics CATX Stock Holding History

Commodore Capital’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6M Hold
6,336,782
– – 1.29% 19
2026
Q1 		$26.4M Buy
+6,336,782
New +$26.8M 1.53% 22
2024
Q4 		– Sell
-3,350,000
Closed -$44.7M – 34
2024
Q3 		$44.7M Sell
3,350,000
-1,307,345
-28% -$17.4M 2.79% 14
2024
Q2 		$46.4M Buy
4,657,345
+2,552,082
+121% +$36.9M 3.17% 14
2024
Q1 		$25.1M Buy
+2,105,263
New +$18M 1.68% 22

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Commodore Capital's CATX Position: Q2 2026 in Review

Commodore Capital held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 6,336,782 shares worth $21.6M. The position accounts for 1.29% of the portfolio, ranked #19.

Commodore Capital first reported a position in CATX in Q1 2024 and has held it in 5 quarters since. The position peaked at $46.4M in Q2 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Commodore Capital held 6,336,782 shares of Perspective Therapeutics worth $21.6M as of Q2 2026.
  • Commodore Capital left its Perspective Therapeutics share count unchanged in Q2 2026.
  • Perspective Therapeutics made up 1.29% of Commodore Capital's portfolio in Q2 2026, its #19 holding.
  • Commodore Capital first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • Commodore Capital's Perspective Therapeutics position peaked at $46.4M in Q2 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Commodore Capital's 13F filing for Q2 2026, filed 14 Aug 2026.